Found: 46
Select item for more details and to access through your institution.
Targeting the adaptive molecular landscape of castration-resistant prostate cancer.
- Published in:
- EMBO Molecular Medicine, 2015, v. 7, n. 7, p. 878, doi. 10.15252/emmm.201303701
- By:
- Publication type:
- Article
Biallelic tumour suppressor loss and DNA repair defects in de novo small‐cell prostate carcinoma.
- Published in:
- Journal of Pathology, 2018, v. 246, n. 2, p. 244, doi. 10.1002/path.5137
- By:
- Publication type:
- Article
Circulating Tumor Cells (CTC) and Cell-Free DNA (cfDNA)Workshop 2016: Scientific Opportunities and Logistics for Cancer Clinical Trial Incorporation.
- Published in:
- International Journal of Molecular Sciences, 2016, v. 17, n. 9, p. 1505, doi. 10.3390/ijms17091505
- By:
- Publication type:
- Article
In Brief: Chromothripsis and cancer.
- Published in:
- Journal of Pathology, 2013, v. 231, n. 1, p. 1, doi. 10.1002/path.4220
- By:
- Publication type:
- Article
From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer.
- Published in:
- Journal of Pathology, 2012, v. 227, n. 3, p. 286, doi. 10.1002/path.4047
- By:
- Publication type:
- Article
Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer.
- Published in:
- Journal of Pathology, 2012, v. 227, n. 1, p. 53, doi. 10.1002/path.3987
- By:
- Publication type:
- Article
Next generation patient-derived prostate cancer xenograft models.
- Published in:
- Asian Journal of Andrology, 2014, v. 16, n. 3, p. 407, doi. 10.4103/1008-682X.125394
- By:
- Publication type:
- Article
The diverse heterogeneity of molecular alterations in prostate cancer identified through next-generation sequencing.
- Published in:
- Asian Journal of Andrology, 2013, v. 15, n. 3, p. 301, doi. 10.1038/aja.2013.13
- By:
- Publication type:
- Article
Her2 alterations in muscle-invasive bladder cancer: Patient selection beyond protein expression for targeted therapy.
- Published in:
- Scientific Reports, 2017, p. 42713, doi. 10.1038/srep42713
- By:
- Publication type:
- Article
Discovery of a Metastatic Immune Escape Mechanism Initiated by the Loss of Expression of the Tumour Biomarker Interleukin-33.
- Published in:
- Scientific Reports, 2016, p. 30555, doi. 10.1038/srep30555
- By:
- Publication type:
- Article
A Meta-Analysis Approach for Characterizing Pan-Cancer Mechanisms of Drug Sensitivity in Cell Lines.
- Published in:
- PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0103050
- By:
- Publication type:
- Article
Systematic Identification and Characterization of RNA Editing in Prostate Tumors.
- Published in:
- PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0101431
- By:
- Publication type:
- Article
Use of genome-wide SNP homozygosity mapping in small pedigrees to identify new mutations in VSX2 causing recessive microphthalmia and a semidominant inner retinal dystrophy.
- Published in:
- Human Genetics, 2010, v. 128, n. 1, p. 51, doi. 10.1007/s00439-010-0823-6
- By:
- Publication type:
- Article
A novel loss-of-function mutation in OTX2 in a patient with anophthalmia and isolated growth hormone deficiency.
- Published in:
- Human Genetics, 2010, v. 127, n. 6, p. 721, doi. 10.1007/s00439-010-0820-9
- By:
- Publication type:
- Article
Reduced TFAP2A function causes variable optic fissure closure and retinal defects and sensitizes eye development to mutations in other morphogenetic regulators.
- Published in:
- Human Genetics, 2009, v. 126, n. 6, p. 791, doi. 10.1007/s00439-009-0730-x
- By:
- Publication type:
- Article
Concurrent germline and somatic pathogenic BAP1 variants in a patient with metastatic bladder cancer.
- Published in:
- NPJ Genomic Medicine, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41525-020-0121-8
- By:
- Publication type:
- Article
ShatterProof: operational detection and quantification of chromothripsis.
- Published in:
- BMC Bioinformatics, 2014, v. 15, n. 1, p. 1, doi. 10.1186/1471-2105-15-78
- By:
- Publication type:
- Article
Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients.
- Published in:
- Genome Biology, 2016, v. 17, p. 1, doi. 10.1186/s13059-015-0864-1
- By:
- Publication type:
- Article
Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer.
- Published in:
- Genome Biology, 2014, v. 15, n. 8, p. 1, doi. 10.1186/s13059-014-0426-y
- By:
- Publication type:
- Article
Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF SELECT consortium assay.
- Published in:
- NAR Cancer, 2022, v. 4, n. 2, p. 1, doi. 10.1093/narcan/zcac016
- By:
- Publication type:
- Article
Cell-free DNA concentration and fragment size as a biomarker for prostate cancer.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-84507-z
- By:
- Publication type:
- Article
Evaluating the quantity, quality and size distribution of cell-free DNA by multiplex droplet digital PCR.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-69432-x
- By:
- Publication type:
- Article
Molecular landscape of carcinoma invading bladder muscle: does patient age matter?
- Published in:
- BJU International, 2019, v. 124, n. 5, p. 719, doi. 10.1111/bju.14802
- By:
- Publication type:
- Article
DNA repair defects in prostate cancer: impact for screening, prognostication and treatment.
- Published in:
- BJU International, 2019, v. 123, n. 5, p. 769, doi. 10.1111/bju.14576
- By:
- Publication type:
- Article
Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinoma.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 12, p. 3453, doi. 10.1002/ijc.32430
- By:
- Publication type:
- Article
Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC).
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 1, p. 53, doi. 10.1038/s41416-023-02487-5
- By:
- Publication type:
- Article
Poly-gene fusion transcripts and chromothripsis in prostate cancer.
- Published in:
- Genes, Chromosomes & Cancer, 2012, v. 51, n. 12, p. 1144, doi. 10.1002/gcc.21999
- By:
- Publication type:
- Article
A generalizable machine learning framework for classifying DNA repair defects using ctDNA exomes.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00366-z
- By:
- Publication type:
- Article
Frequent mutation of the FOXA1 untranslated region in prostate cancer.
- Published in:
- Communications Biology, 2018, v. 1, n. 1, p. N.PAG, doi. 10.1038/s42003-018-0128-1
- By:
- Publication type:
- Article
Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer.
- Published in:
- Journal of Pathology: Clinical Research, 2021, v. 7, n. 4, p. 311, doi. 10.1002/cjp2.203
- By:
- Publication type:
- Article
Immunocytochemistry for ARID1A as a potential biomarker in urine cytology of bladder cancer.
- Published in:
- Cancer Cytopathology, 2019, v. 127, n. 9, p. 578, doi. 10.1002/cncy.22167
- By:
- Publication type:
- Article
Genomic biomarkers to guide precision radiotherapy in prostate cancer.
- Published in:
- Prostate, 2022, v. 82, p. S73, doi. 10.1002/pros.24373
- By:
- Publication type:
- Article
Androgen receptor genomic alterations and treatment resistance in metastatic prostate cancer.
- Published in:
- Prostate, 2022, v. 82, p. S25, doi. 10.1002/pros.24356
- By:
- Publication type:
- Article
Bone morphogenetic protein 7 ( BMP7) mutations are associated with variable ocular, brain, ear, palate, and skeletal anomalies.
- Published in:
- Human Mutation, 2010, v. 31, n. 7, p. 781, doi. 10.1002/humu.21280
- By:
- Publication type:
- Article
TP53 Alterations Are Associated With Poor Survival in Patients With Primary Mediastinal Nonseminoma Germ Cell Tumors.
- Published in:
- Oncologist, 2022, v. 27, n. 11, p. e912, doi. 10.1093/oncolo/oyac197
- By:
- Publication type:
- Article
Biomarkers for Programmed Death‐1 Inhibition in Prostate Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 444, doi. 10.1634/theoncologist.2018-0546
- By:
- Publication type:
- Article
Towards clinical implementation of circulating tumor DNA in metastatic prostate cancer: Opportunities for integration and pitfalls to interpretation.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1054497
- By:
- Publication type:
- Article
Differential treatment outcomes in BRCA1/2-, CDK12-, and ATM-mutated metastatic castration-resistant prostate cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
SiNVICT: ultra-sensitive detection of single nucleotide variants and indels in circulating tumour DNA.
- Published in:
- Bioinformatics, 2017, v. 33, n. 1, p. 26, doi. 10.1093/bioinformatics/btw536
- By:
- Publication type:
- Article
Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 1, p. 115, doi. 10.1093/jnci/djad184
- By:
- Publication type:
- Article
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2018, v. 110, n. 1, p. 1, doi. 10.1093/jnci/djx118
- By:
- Publication type:
- Article
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-020-20493-6
- By:
- Publication type:
- Article
2023 Canadian Urological Association guideline: Genetic testing in prostate cancer.
- Published in:
- Canadian Urological Association Journal, 2023, v. 17, n. 10, p. 314, doi. 10.5489/cuaj.8588
- By:
- Publication type:
- Article
Considerations on the identification and management of metastatic prostate cancer patients with DNA repair gene alterations in the Canadian context.
- Published in:
- Canadian Urological Association Journal, 2022, v. 16, n. 4, p. 132, doi. 10.5489/cuaj.7621
- By:
- Publication type:
- Article
The evolving role of germline genetic testing and management in prostate cancer: Report from the Princess Margaret Cancer Centre international retreat.
- Published in:
- Canadian Urological Association Journal, 2021, v. 15, n. 12, p. E623, doi. 10.5489/cuaj.7383
- By:
- Publication type:
- Article